Expert Analysis

Diagnostics and New Drugs

Source: CCO Independent Conference Coverage of the 2004 Annual Meeting of The American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Diagnostics and New Drugs


Program Director: Patrick J. Lynch, MD

Faculty:

Geoffrey M. Dusheiko, MD, FCP(SA), FRCPRobert G. Gish, MDJean-Michel Pawlotsky, MD, PhD
  • Geoffrey M. Dusheiko, MD, FCP(SA), FRCP
  • Robert G. Gish, MD
  • Jean-Michel Pawlotsky, MD, PhD

CME CREDIT INFORMATION

Release Date: 12/21/04

Expiration Date: 12/20/05


Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 3.6 Nursing CE credits

Pharmacists: 3.0 contact hours (0.3 CEUs)

Status: Please log in to view status

Begin the Expert Analysis

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review studies of invasive and noninvasive diagnostic tests of liver fibrosis and inflammation

  • Evaluate studies of the sensitivity and specificity of current and new tests for the quantitative and qualitative diagnosis of viral hepatitis

  • Discuss recent studies of drugs in early-stage clinical trials for the treatment of viral hepatitis


Earn CME credit by reading the expert analysis and commentary on Diagnostics and New Drugs.

Topics covered include:

  • Novel Tools for Assessing Functional Liver Activity
  • Innovations in Measuring Viral Hepatitis C
  • HCV Core Antigen Enzyme Immunoassay (EIA)
  • Clevudine
  • Combination vs Single-Agent Therapy
  • Entecavir
  • Tenofovir
  • Liver-Targeted Prodrugs: Remofovir and Viramidine
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.